High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium

被引:36
作者
Ihara, M
Urata, H
Shirai, K
Ideishi, M
Hoshino, F
Suzumiya, J
Kikuchi, M
Arakawa, K
机构
[1] Fukuoka Univ, Sch Med, Dept Internal Med, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 8140180, Japan
关键词
angiotensin-II-forming enzyme; chymase; angiotensin-converting enzyme; mast cell; inflammatory cell; cardiac renin-angiotensin system; myocardial infarction; cardiac remodeling;
D O I
10.1159/000047325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to compare human cardiac angiotensin-II-forming activity (AIIFA) between the intact area of control autopsy hearts without cardiac disease (n = 10) and the infarcted or non-infarcted area of autopsy hearts with myocardial infarction (MI, n = 7) and to determine responsible angiotensin-ll-forming enzymes. Cardiac total and chymase-dependent AIIFAs were significantly higher in the infarcted and non-infarcted myocardium than those in non-Mi heart, while angiotensin-converting enzyme-dependent AIIFA increased only in the infarcted myocardium, The density of chymase antibody-positive mast cells in the non-infarcted area of MI heart correlated positively with total or chymase-dependent AIIFA, Augmented AIIFA was also detected in the left atrium of post-MI hearts. Our results indicated that cardiac angiotensin II formation could be activated in the infarcted as well as in non-infarcted myocardium of the post-MI human heart, Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 25 条
[1]   Differences in tissue angiotensin II-forming pathways by species and organs in vitro [J].
Akasu, M ;
Urata, H ;
Kinoshita, A ;
Sasaguri, M ;
Ideishi, M ;
Arakawa, K .
HYPERTENSION, 1998, 32 (03) :514-520
[2]  
Arakawa K, 1996, J HYPERTENS, V14, pS3
[3]   Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation [J].
DellItalia, LJ ;
Meng, QC ;
Balcells, E ;
StraeterKnowlen, IM ;
Hankes, GH ;
Dillon, R ;
Cartee, ER ;
Orr, R ;
Bishop, SP ;
Oparil, S ;
Elton, TS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (06) :H2065-H2073
[4]   TRANSMURAL CHANGES IN MAST-CELL DENSITY IN RAT-HEART AFTER INFARCT INDUCTION IN-VIVO [J].
ENGELS, W ;
REITERS, PHCM ;
DAEMEN, MJAP ;
SMITS, JFM ;
VANDERVUSSE, GJ .
JOURNAL OF PATHOLOGY, 1995, 177 (04) :423-429
[5]   LIMITATION OF EXPERIMENTAL INFARCT SIZE BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ERTL, G ;
KLONER, RA ;
ALEXANDER, RW ;
BRAUNWALD, E .
CIRCULATION, 1982, 65 (01) :40-48
[6]   TISSUE-SPECIFIC ACTIVATION OF CARDIAC ANGIOTENSIN CONVERTING ENZYME IN EXPERIMENTAL HEART-FAILURE [J].
HIRSCH, AT ;
TALSNESS, CE ;
SCHUNKERT, H ;
PAUL, M ;
DZAU, VJ .
CIRCULATION RESEARCH, 1991, 69 (02) :475-482
[7]   Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction [J].
Hokimoto, S ;
Yasue, H ;
Fujimoto, K ;
Yamamoto, H ;
Nakao, K ;
Kaikita, K ;
Sakata, R ;
Miyamoto, E .
CIRCULATION, 1996, 94 (07) :1513-1518
[8]   Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta [J].
Ihara, M ;
Urata, H ;
Kinoshita, A ;
Suzumiya, J ;
Sasaguri, M ;
Kikuchi, M ;
Ideishi, M ;
Arakawa, K .
HYPERTENSION, 1999, 33 (06) :1399-1405
[9]   CHANGES IN CARDIAC ANGIOTENSIN CONVERTING ENZYME AFTER MYOCARDIAL-INFARCTION AND HYPERTROPHY IN RATS [J].
JOHNSTON, CI ;
MOOSER, V ;
SUN, Y ;
FABRIS, B .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1991, 18 (02) :107-110
[10]   SERIAL ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR GEOMETRY AND FUNCTION AFTER LARGE MYOCARDIAL-INFARCTION IN THE RAT [J].
LITWIN, SE ;
KATZ, SE ;
MORGAN, JP ;
DOUGLAS, PS .
CIRCULATION, 1994, 89 (01) :345-354